Current Trends in the Development of EGFR Inhibitors as Promising AnticancerAgents: Sar and Synthetic Studies from (2010-2020)
Sitanshu Mondal(Indo Soviet Friendship College of Pharmacy), Preeti Patel(Indo Soviet Friendship College of Pharmacy), Simranpreet K. Wahan(Punjab Technical University), S. Vishakha(Indo Soviet Friendship College of Pharmacy), Kumari Kajal(Indo Soviet Friendship College of Pharmacy), Balak Das Kurmi(Indo Soviet Friendship College of Pharmacy)
Cited by 3
Related Papers
Solid lipid nanoparticles: a review on recent perspectives and patents
|Expert Opinion on Therapeutic Patents|2020|323
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Micro- and nanocarrier-mediated lung targeting
|Expert Opinion on Drug Delivery|2010|121
Transdermal Drug Delivery: Opportunities and Challenges for Controlled Delivery of Therapeutic Agents Using Nanocarriers
|Current Drug Metabolism|2017|107